Fig. 3From: Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patientsClinical outcome with regard to chemotherapy-related survival. The subgroups were compared with the log-rank test. The Kaplan–Meier analyses of chemotherapy-free survival (a), fluoropyrimidine-free survival (b), and platinum-free survival (c) in individuals with gastric cancer in TCGA are shownBack to article page